The University of Western Ontario

Wong, E., J. Van Dyk, J.J. Battista, R.B. Barnett, and P.N. Munro. 1997. Uncertainty Analysis: A Guide to Optimization in Radiation Treatment Planning. Proceedings of the XIIth International Conference on the Use of Computers in Radiation Therapy. Salt Lake City, Utah: Leavitt DD, Starkschall G. Medical Physics Publishing. 259-261.

Battista, J.J., M.B. Sharpe, E. Wong, and J. Van Dyk. 1997. A new Classification Scheme for Photon Beam Dose Algorithms. Proceedings of the XIIth International Conference on the Use of Computers in Radiation Therapy. Leavitt D.D., and G. Starkschall. Salt Lake City, Utah: Medical Physics Publishing. 39-42.

Lazarescu, G., and J.J. Battista. 1997. Analysis of the Radiobiology of Ytterbium-169 and Iodine-125 Permanent Brachytherapy Implants. Physics In Medicine and Biology 42: 1727-1736.

Sharpe, M.B., E. Wong, J. Van Dyk, and J.J. Battista. 1997. Accounting for the X-ray Energy Spectrum in Superposition Dose Calculations. Proceedings of the XIIth International Conference on the Use of Computers in Radiation Therapy. D.D. Leavitt, and G. Starkschall. Salt Lake City, Utah: Medical Physics Publishing. 103-107.

Wong, E., J. Van Dyk, J.J. Battista, R.B. Barnett, and P.N. Munro. 1997. Uncertainty Analysis: A Guide to Optimization in Radiation Treatment Planning. Proceedings of the XIIth International Conference on the Use of Computers in Radiation Therapy. Salt Lake City, Utah: Leavitt DD, Starkschall G. Medical Physics Publishing. 259-261.

Bauman, G.S., P.K. Sneed, W.M. Wara, L.J. Stalpers, S.M. Chang, M.W. McDermott, P.H. Gutin, and D.A. Larson. 1996. Reirradiation of Primary CNS Tumors. International Journal of Radiation Oncology, Biology, Physics 36 (2): 433-441.

Leighton, C., B.J. Fisher, G.S. Bauman, S. Depiero, L.W. Stitt, D.R. Macdonald, and J.G. Cairncross. 1997. Supratentorial Low-Grade Glioma in Adults: An Analysis of Prognostic Factors and Timing of Radiation. Journal of Clinical Oncology 15 (4): 1294-1301.

Blackstein, M.E., A.E. Waddell, A.M. Davis, H. Ahn, J.S. Wunder, R.S. Bell, and V.H.C. Bramwell. 1996. Management of non-osteogenic spindle sarcoma of bone. Connective Tissue Oncology Society.

Bramwell, V.H.C. 1996. Identification of randomized controlled trials (RCT) in sarcoma. Proceedings 5th Annual Cochrane Colloquium.

Bramwell, V.H.C. 1997. The Role of Chemotherapy in the Management of Non-Metastatic Operable Extremity Osteosarcoma. Seminars in Oncology 24: 561-571.

Gortzak, E., J. Rouesse, J. Verweij, A. Santoro, A. Ezzat, J. Buesa, V.H.C. Bramwell, M. Van Glabbeke, A. Kirkpatrick, and T. Tursz. 1996. Randomized Phase II Study of Neoadjuvant Chemotherapy in Soft Tissue Sarcomas in Adults: EORTC Protocol 62874. Connective Tissue Oncology Society.

Mertens, W., and V.H.C. Bramwell. 1996. Osteosarcoma and Other Tumors of Bone. Current Opinions in Oncology 8: 299-304.

Mertens, W., and V.H.C. Bramwell. 1997. Osteosarcoma and Other Tumors of Bone. Current Opinions in Oncology 9: 360-365.

O'Malley, F.P., S. Saad, N. Kerkvliet, G.S. Doig, L.W. Stitt, P.J. Ainsworth, A.F. Chambers, D.I. Turnbull, and V.H.C. Bramwell. 1996. The Predictive Power of Semi-quantitative Immunohistochemical analysis of p53 and c-erb B2 in lymph node negative breast cancer. Human Pathology 27: 955-963.

Pritchard, K., A.H.G. Paterson, S. Fine, N.A. Paul, B. Zee, L.E. Shepherd, H. Abu-Zahra, J. Ragaz, M. Knowling, M.N. Levine, S. Verma, D. Perrault, P.L.D. Walde, V.H.C. Bramwell, M. Polijicak, N. Boyd, D. Warr, B.D. Norris, D. Bowman, G.R. Armitage, H. Weizel, and R.A. Buckman. 1997. A Randomized Trial of CMF Chemotherapy added to Tamoxifen as Adjuvant Therapy in Postmenopausal Women with Node Positive Estrogen (ER) and/or Progesterone Receptor (PgR) Positive Breast Cancer: A Report of the National Cancer Institute of Canada Clinical Trials Group (NCICCTG) Trial MA.4. Journal of Clinical Oncology 15: 2302-2311.

Souhami, R.L., A.W. Craft, J.W. van der Eijken, M. Nooij, D. Spooner, V.H.C. Bramwell, R. Wierzbicki, A.J. Malcolm, A. Kirkpatrick, B.M. Uscinska, M. Van Glabbeke, and D. Machin. 1997. A Randomized Trial of Two Regimens of Chemotherapy in Operable Osteosarcoma: A Study of the European Osteosarcoma Intergroup. Lancet 350: 911-917.

Winquist, E., J. Kuruvilla, P. Kuruvilla, F.E. Perera, and V.H.C. Bramwell. 1997. The Effect of Geographic Distance on Use of Clinical Practice Guidelines (CPGs) for Systemic Adjuvant Therapy of Breast Cancer. Proceedings American Society of Clinical Oncology 16: 414a.

Cairncross, J.G. 1997. Oligodendroglioma and Mixed Gliomas(Chapter 28). Cancer of the Nervous System. P.M. Black, and J.S. Loeffler. Cambridge, UK: Blackwell Scientific. 549-557.

DeAngelis, L.M., and J.G. Cairncross. 1997. Tumors of the Nervous System. Textbook of Internal Medicine. 3rd ed. W.N. Kelley. Philadelphia, PA: Lippincott. 2331-2339.

Forsyth, P., and J.G. Cairncross. 1996. Chemotherapy for Malignant Glioma. Clinical Neurology - Cerebral Gliomas. 5th ed. W.K.A. Yung. London, UK: Bailliere Tindall. 371-393.

Forsyth, P., J.G. Cairncross, D. Stewart, M. Goodyear, N. Wainman, and E. Eisenhauer. 1996. Phase II trial of docetaxel in patients with recurrent malignant gliomas: a study of the National Cancer Institute of Canada'. Investigational New Drugs 14: 203-206.

Forsyth, P., E. Petrov, H. Mahallati, J.G. Cairncross, P. Brasher, M.E. MacRae, N.A. Hagen, P. Barnes, and R.J. Sevick. 1997. Prospective study of postoperative magnetic resonance imaging in patients with malignant gliomas. Journal of Clinical Oncology 15 (5): 2076-2081.

Gao, L., Liu, D. van Meyel, J.G. Cairncross, P. Forsyth, D. Kimmel, R. Jenkins, N. Lassam, and D. Hogg. 1997. Lack of Germline Mutations of CDK4, p16INK4A and p15INK4B in families with glioma. Clinical and Cancer Research 3: 977-982.

Irish, W.D., D.R. Macdonald, and J.G. Cairncross. 1997. Measuring bias in uncontrolled brain tumor trials - to randomize or not to randomize? Canadian Journal of Neurological Sciences 24: 307-312.

Leighton, C., B.J. Fisher, G.S. Bauman, S. Depiero, L.W. Stitt, D.R. Macdonald, and J.G. Cairncross. 1997. Supratentorial Low-Grade Glioma in Adults: An Analysis of Prognostic Factors and Timing of Radiation. Journal of Clinical Oncology 15 (4): 1294-1301.

Mason, W., D.N. Louis, and J.G. Cairncross. 1997. Chemosensitive Gliomas in Adults: Which Ones, Why? Journal of Clinical Oncology 15: 3423-3426.

Perry, J.R., L.M. DeAngelis, S.C.J.R. Schold, P.C. Burger, M.T. Brown, H.S. Brem, W.J. Curran, C.B. Scott, M.D. Prados, R. Kaplan, and J.G. Cairncross. 1997. Challenges in the design and conduct of phase III brain tumor therapy trials. Neurology 49: 912-917.

Peterson, K., N. Paleologos, P. Forsyth, D.R. Macdonald, and J.G. Cairncross. 1996. Salvage chemotherapy for oligodendroglioma. Journal of Neurosurgery 85: 597-601.

Schabet, M., and J.G. Cairncross. 1996. Brain Metastases from Systemic Solid Tumors (Chapter 54). Neurological Disorders: Course and Treatment. T. Brandt, L.R. Caplan, J. Dichgans, H.C. Diener, and C. Kennard. San Diego, CA: Academic Press. 605-616.

Schold, S.C.J.R., J.G. Cairncross, and R. Sajpaul. 1996. Chemotherapy of Primary Central Nervous System Neoplasms. Neurosurgery. R.H. Wilkins, and S.S. Rengachary. New York, NY: McGraw-Hill. 1957-1966.

Chambers, A.F., S.M. Wilson, N. Kerkvliet, F.P. O'Malley, J.F. Harris, and A.G. Casson. 1996. Osteopontin expression in lung cancer. Lung Cancer 15: 311-323.

Engel, C.J., S.T. Bennett, A.F. Chambers, G.S. Doig, N. Kerkvliet, and F.P. O'Malley. 1996. Tumor angiogenesis predicts recurrence in invasive colorectal cancer when controlled for Dukes staging. American Journal of Surgical Pathology 20: 1260-1265.

Guthrie, N., A. Gapor, A.F. Chambers, and K.K. Carroll. 1997. Inhibition of proliferation of estrogen receptor-negative MDA-MB-435 and -positive MCF-7 human breast cancer cells by palm oil tocotrienols and tamoxifen, alone and in combination. Journal of Nutrition 127: 544S-548S.

Hahn, F.M., J.W. Xuan, A.F. Chambers, and C.D. Poulter. 1996. Human Isopentenyl Diphosphate: Dimethylally1 diphosphate isomerase: overproduction purification and characterization. Archives of Biochemistry and Biophysics 332: 30-34.

Koop, S., E.E. Schmidt, I.C. MacDonald, V.L. Morris, R. Khokha, M. Grattan, J. Leone, A.F. Chambers, and A.C. Groom. 1996. Independence of metastatic ability and extravasation: Metastatic ras-transformed and control fibroblasts extravasate equally. Proceedings of the National Academy of Sciences 93: 1080-1084.

MacNeil, R.L., C. Strayhorn, J. Berry, D.S. Bautista, J.F. Harris, A.F. Chambers, and M.J. Somerman. 1996. Osteopontin is localized and expressed at specific sites during tooth eruption. Biological Mechanisms of Tooth Movement and Craniofacial Adaption. Davidovitch Z., and L.A. Norton. Boston, MA: Harvard Society for the Advancement of Orthodontics. 123-131.

O'Malley, F.P., S. Saad, N. Kerkvliet, G.S. Doig, L.W. Stitt, P.J. Ainsworth, A.F. Chambers, D.I. Turnbull, and V.H.C. Bramwell. 1996. The Predictive Power of Semi-quantitative Immunohistochemical analysis of p53 and c-erb B2 in lymph node negative breast cancer. Human Pathology 27: 955-963.

Singhal, H., D.S. Bautista, K.S. Tonkin, F.P. O'Malley, A.B. Tuck, A.F. Chambers, and J.F. Harris. 1997. Elevated plasma osteopontin in metastatic breast cancer associated with increased tumor burden and decreased survival. Clinical Cancer Research 3: 605-611.

So, F.V., N. Guthrie, A.F. Chambers, and K.K. Carroll. 1997. Inhibition of proliferation of estrogen receptor-positive MCF-7 human breast cancer cells by flavonoids in the presence and absence of excess estrogen. Cancer Letters 112: 127-133.

Tuck, A.B., F.P. O'Malley, H. Singhal, K.S. Tonkin, J.F. Harris, D.S. Bautista, and A.F. Chambers. 1997. Osteopontin (OPN) and p53 Expression are Associated with Tumor Progression in a Case of Synchronous, Bilateral, Invasive Mammary Carcinomas. Archives of Pathology and Laboratory Medicine 121: 578-584.

Chan, R.H., A.R. Dar, L.W. Stitt, F. Whiston, E. Yu, P.T. Truong, M.D. Vincent, and W.I. Kocha. 1997. Superior vena cava obstruction in small cell lung cancer. International Journal of Radiation Oncology, Biology, Physics 38: 513-520.

DiMattia, G.E., S.J. Rhodes, A. Krones, C. Carriere, S. O'Connell, K. Kalla, C. Arias, P. Sawchenko, and M.G. Rosenfeld. 1997. The PIT-1 gene is regulated by distinct early and late pituitary-specific enhancers. Developmental Biology 182: 180-190.

Bissonnette, J.P., I.A. Cunningham, D.A. Jaffray, A. Fenster, and P.N. Munro. 1997. A quantum accounting and detective quantum efficiency analysis for video-based portal imaging. Medical Physics 24: 815-826.

Leighton, C., B.J. Fisher, G.S. Bauman, S. Depiero, L.W. Stitt, D.R. Macdonald, and J.G. Cairncross. 1997. Supratentorial Low-Grade Glioma in Adults: An Analysis of Prognostic Factors and Timing of Radiation. Journal of Clinical Oncology 15 (4): 1294-1301.

Perrault, D., E. Eisenhauer, K. Pritchard, L. Panasci, B. Norris, T.A. Vandenberg, and B.J. Fisher. 1996. Phase II Study of the Progesterone Antagonist Mifepristone in Patients with Untreated Metastatic Breast Carcinoma: A National Cancer Institute of Canada Clinical Trials Group Study. Journal of Clinical Oncology 14 (10): 2709-2712.

Chambers, A.F., S.M. Wilson, N. Kerkvliet, F.P. O'Malley, J.F. Harris, and A.G. Casson. 1996. Osteopontin expression in lung cancer. Lung Cancer 15: 311-323.

MacNeil, R.L., C. Strayhorn, J. Berry, D.S. Bautista, J.F. Harris, A.F. Chambers, and M.J. Somerman. 1996. Osteopontin is localized and expressed at specific sites during tooth eruption. Biological Mechanisms of Tooth Movement and Craniofacial Adaption. Davidovitch Z., and L.A. Norton. Boston, MA: Harvard Society for the Advancement of Orthodontics. 123-131.

Singhal, H., D.S. Bautista, K.S. Tonkin, F.P. O'Malley, A.B. Tuck, A.F. Chambers, and J.F. Harris. 1997. Elevated plasma osteopontin in metastatic breast cancer associated with increased tumor burden and decreased survival. Clinical Cancer Research 3: 605-611.

Tuck, A.B., F.P. O'Malley, H. Singhal, K.S. Tonkin, J.F. Harris, D.S. Bautista, and A.F. Chambers. 1997. Osteopontin (OPN) and p53 Expression are Associated with Tumor Progression in a Case of Synchronous, Bilateral, Invasive Mammary Carcinomas. Archives of Pathology and Laboratory Medicine 121: 578-584.

Chan, R.H., A.R. Dar, L.W. Stitt, F. Whiston, E. Yu, P.T. Truong, M.D. Vincent, and W.I. Kocha. 1997. Superior vena cava obstruction in small cell lung cancer. International Journal of Radiation Oncology, Biology, Physics 38: 513-520.

Koropatnick, D.J., J. DeMoor, O. Collins, and M.D. Vincent . 1997. Discrimination of run-on transcription from constitutive genes and antisense expression vectors in the same cells. BioTechniques 22: 64-66.

Koropatnick, D.J., and R.K. Zalups. 1997. Effect of non-toxic mercury and cadmium pretreatment on the capacity of human monocytes to undergo lipopolysaccharide-induced. British Journal of Pharmacology 120: 797-806.

Ono, S., D.J. Koropatnick, and M.G. Cherian. 1997. Regional brain distribution of metallothionein, zinc and copper in toxic milk mutant and transgenic mice. Toxicology 124: 1-10.

Irish, W.D., D.R. Macdonald, and J.G. Cairncross. 1997. Measuring bias in uncontrolled brain tumor trials - to randomize or not to randomize? Canadian Journal of Neurological Sciences 24: 307-312.

Leighton, C., B.J. Fisher, G.S. Bauman, S. Depiero, L.W. Stitt, D.R. Macdonald, and J.G. Cairncross. 1997. Supratentorial Low-Grade Glioma in Adults: An Analysis of Prognostic Factors and Timing of Radiation. Journal of Clinical Oncology 15 (4): 1294-1301.

Peterson, K., N. Paleologos, P. Forsyth, D.R. Macdonald, and J.G. Cairncross. 1996. Salvage chemotherapy for oligodendroglioma. Journal of Neurosurgery 85: 597-601.

Koop, S., E.E. Schmidt, I.C. MacDonald, V.L. Morris, R. Khokha, M. Grattan, J. Leone, A.F. Chambers, and A.C. Groom. 1996. Independence of metastatic ability and extravasation: Metastatic ras-transformed and control fibroblasts extravasate equally. Proceedings of the National Academy of Sciences 93: 1080-1084.

Bissonnette, J.P., I.A. Cunningham, D.A. Jaffray, A. Fenster, and P.N. Munro. 1997. A quantum accounting and detective quantum efficiency analysis for video-based portal imaging. Medical Physics 24: 815-826.

Bissonnette, J.P., I.A. Cunningham, D.A. Jaffray, and P.N. Munro. 1997. Optimal phosphor thickness for portal imaging. Medical Physics 24: 803-814.

Wong, E., J. Van Dyk, J.J. Battista, R.B. Barnett, and P.N. Munro. 1997. Uncertainty Analysis: A Guide to Optimization in Radiation Treatment Planning. Proceedings of the XIIth International Conference on the Use of Computers in Radiation Therapy. Salt Lake City, Utah: Leavitt DD, Starkschall G. Medical Physics Publishing. 259-261.

Chambers, A.F., S.M. Wilson, N. Kerkvliet, F.P. O'Malley, J.F. Harris, and A.G. Casson. 1996. Osteopontin expression in lung cancer. Lung Cancer 15: 311-323.

Engel, C.J., S.T. Bennett, A.F. Chambers, G.S. Doig, N. Kerkvliet, and F.P. O'Malley. 1996. Tumor angiogenesis predicts recurrence in invasive colorectal cancer when controlled for Dukes staging. American Journal of Surgical Pathology 20: 1260-1265.

O'Malley, F.P., S. Saad, N. Kerkvliet, G.S. Doig, L.W. Stitt, P.J. Ainsworth, A.F. Chambers, D.I. Turnbull, and V.H.C. Bramwell. 1996. The Predictive Power of Semi-quantitative Immunohistochemical analysis of p53 and c-erb B2 in lymph node negative breast cancer. Human Pathology 27: 955-963.

Singhal, H., D.S. Bautista, K.S. Tonkin, F.P. O'Malley, A.B. Tuck, A.F. Chambers, and J.F. Harris. 1997. Elevated plasma osteopontin in metastatic breast cancer associated with increased tumor burden and decreased survival. Clinical Cancer Research 3: 605-611.

Tuck, A.B., F.P. O'Malley, H. Singhal, K.S. Tonkin, J.F. Harris, D.S. Bautista, and A.F. Chambers. 1997. Osteopontin (OPN) and p53 Expression are Associated with Tumor Progression in a Case of Synchronous, Bilateral, Invasive Mammary Carcinomas. Archives of Pathology and Laboratory Medicine 121: 578-584.

Winquist, E., J. Kuruvilla, P. Kuruvilla, F.E. Perera, and V.H.C. Bramwell. 1997. The Effect of Geographic Distance on Use of Clinical Practice Guidelines (CPGs) for Systemic Adjuvant Therapy of Breast Cancer. Proceedings American Society of Clinical Oncology 16: 414a.

Greenberg, P., R. Advani, A. Keating, S.C. Gulati, S. Nimer, R. Champlin, C. Karanes, N.C. Gorin, R.L. Powles, A.M. Smith, K. Lamborn, and C. Cuffie. 1996. GM-CSF accelerates neutrophil recovery after autologous hematopoietic stem cell transplantation. Bone Marrow Transplantation 18: 1057-1064.

Smith, A.M., N. Berinstein, J. Connors, L. Huebsch, A. Keating, H. Messner, and R. Meyer. 1997. Maximizing the benefits of myeloablative therapy and transplantation. Current Oncology 4: 125-130.

Vose, J.M., A.N. Pandite, R.A. Beveridge, R.B. Geller, M.W. Schuster, J.E. Anderson, C.F. LeMaistre, T. Ahmed, A. Granena, A. Keating, J.M. Ranada, P.J. Stiff, I. Tabbara, W. Longo, E.A. Copelan, C. Nichols, A.M. Smith, D.L. Topolsky, P.J. Bierman, M.E. Lebsack, M. Lange, and L. Garrison. 1997. Granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein versus granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for non-Hodgkin's lymphoma: Results of a randomized double-blind trial. Journal of Clinical Oncology 15: 1617-1623.

Singhal, H., D.S. Bautista, K.S. Tonkin, F.P. O'Malley, A.B. Tuck, A.F. Chambers, and J.F. Harris. 1997. Elevated plasma osteopontin in metastatic breast cancer associated with increased tumor burden and decreased survival. Clinical Cancer Research 3: 605-611.

Tuck, A.B., F.P. O'Malley, H. Singhal, K.S. Tonkin, J.F. Harris, D.S. Bautista, and A.F. Chambers. 1997. Osteopontin (OPN) and p53 Expression are Associated with Tumor Progression in a Case of Synchronous, Bilateral, Invasive Mammary Carcinomas. Archives of Pathology and Laboratory Medicine 121: 578-584.

Chan, R.H., A.R. Dar, L.W. Stitt, F. Whiston, E. Yu, P.T. Truong, M.D. Vincent, and W.I. Kocha. 1997. Superior vena cava obstruction in small cell lung cancer. International Journal of Radiation Oncology, Biology, Physics 38: 513-520.

Battista, J.J., M.B. Sharpe, E. Wong, and J. Van Dyk. 1997. A new Classification Scheme for Photon Beam Dose Algorithms. Proceedings of the XIIth International Conference on the Use of Computers in Radiation Therapy. Leavitt D.D., and G. Starkschall. Salt Lake City, Utah: Medical Physics Publishing. 39-42.

Sharpe, M.B., E. Wong, J. Van Dyk, and J.J. Battista. 1997. Accounting for the X-ray Energy Spectrum in Superposition Dose Calculations. Proceedings of the XIIth International Conference on the Use of Computers in Radiation Therapy. D.D. Leavitt, and G. Starkschall. Salt Lake City, Utah: Medical Physics Publishing. 103-107.

Wong, E., J. Van Dyk, J.J. Battista, R.B. Barnett, and P.N. Munro. 1997. Uncertainty Analysis: A Guide to Optimization in Radiation Treatment Planning. Proceedings of the XIIth International Conference on the Use of Computers in Radiation Therapy. Salt Lake City, Utah: Leavitt DD, Starkschall G. Medical Physics Publishing. 259-261.

Wong, E., Y. Zhu, and J. Van Dyk. 1996. Theoretical Developments on FFT Convolution Dose Calculations in Inhomogeneous Media. Medical Physics 23: 1511-1521.

Perrault, D., E. Eisenhauer, K. Pritchard, L. Panasci, B. Norris, T.A. Vandenberg, and B.J. Fisher. 1996. Phase II Study of the Progesterone Antagonist Mifepristone in Patients with Untreated Metastatic Breast Carcinoma: A National Cancer Institute of Canada Clinical Trials Group Study. Journal of Clinical Oncology 14 (10): 2709-2712.

Chan, R.H., A.R. Dar, L.W. Stitt, F. Whiston, E. Yu, P.T. Truong, M.D. Vincent, and W.I. Kocha. 1997. Superior vena cava obstruction in small cell lung cancer. International Journal of Radiation Oncology, Biology, Physics 38: 513-520.

Koropatnick, D.J., J. DeMoor, O. Collins, and M.D. Vincent . 1997. Discrimination of run-on transcription from constitutive genes and antisense expression vectors in the same cells. BioTechniques 22: 64-66.

Meropol, N.J., R. Pazdur, M.D. Vincent, J.K.V. Willson, D.P. Kelson, and H.O. Douglass. 1996. Phase II study of ZD1694 in patients with advanced gastric cancer. American Journal of Clinical Oncology 19: 628-630.

Pazdur, R., N.J. Meropol, E.S. Casper, C. Fuchs, H.O. Douglass, M.D. Vincent, and J.L. Abbruzzese. 1996. Phase II trial of ZD1694 (Tomudex) in patients with advanced pancreatic cancer. Investigational New Drugs 13: 355-358.

Winquist, E., J. Kuruvilla, P. Kuruvilla, F.E. Perera, and V.H.C. Bramwell. 1997. The Effect of Geographic Distance on Use of Clinical Practice Guidelines (CPGs) for Systemic Adjuvant Therapy of Breast Cancer. Proceedings American Society of Clinical Oncology 16: 414a.

Chan, R.H., A.R. Dar, L.W. Stitt, F. Whiston, E. Yu, P.T. Truong, M.D. Vincent, and W.I. Kocha. 1997. Superior vena cava obstruction in small cell lung cancer. International Journal of Radiation Oncology, Biology, Physics 38: 513-520.